Razvigor Borislavov Darlenski

Prof. Dr. Razvigor Borislavov Darlenski

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2014 in Clinics in Dermatology
Verified
Journal Article
Closed access
RDRazvigor Borislavov Darlenski
Razvigor Borislavov Darlenski
JKJana Kazandjieva
Jana Kazandjieva
EHEvgeniya Hristakieva
Evgeniya Hristakieva
JFJoachim W. Fluhr
Joachim W. Fluhr

1 May 2012 in Clinics in Dermatology
Verified
Journal Article
Closed access
RDRazvigor Borislavov Darlenski
Razvigor Borislavov Darlenski
JFJoachim W. Fluhr
Joachim W. Fluhr

23 September 2013 in Experimental Dermatology
Verified
Journal Article
Open access
PDF file
RDRazvigor Borislavov Darlenski
Razvigor Borislavov Darlenski
JKJana Kazandjieva
Jana Kazandjieva
NTNikolai Tsankov
Nikolai Tsankov
JFJoachim W. Fluhr
Joachim W. Fluhr
The aim of the study was to disclose interactions between epidermal barrier, skin irritation and sensitization in healthy and diseased skin. Transepidermal water loss (TEWL) and stratum corneum hydration (SCH) were assessed in adult patients with atopic dermatitis (AD), rosacea and healthy controls. A 4‐h patch test with seven concentrations of sodium lauryl sulphate was performed to determine the irritant threshold (IT). Contact sensitization pattern was revealed by patch testing with European baseline series. Subjects with a lower IT had higher TEWL values and lower SCH. Subjects with positive allergic reactions had significantly lower IT. In AD, epidermal barrier deterioration was detected on both volar forearm and nasolabial fold, while in rosacea, impeded skin physiology parameters were observed on the facial skin only, suggesting that barrier impediment is restricted to the face in rosacea, in contrast with AD where the abnormal skin physiology is generalized.

10 March 2022 in Frontiers in Nutrition
Verified
Journal Article
Open access
RDRazvigor Borislavov Darlenski
Razvigor Borislavov Darlenski
VMVesselina Mihaylova
Vesselina Mihaylova
THTeodora Handjieva-Darlenska
Teodora Handjieva-Darlenska
Obesity as a multi-organ disease that affects the entire human organism. Notably, the skin is no exclusion from this postulate. Skin changes in obese patients have been widely studied with regards to mechanical friction, skin infections, and skin hypertrophic conditions, such as acanthosis nigricans and, most commonly, fibromas (skin tags). Almost 60–70% of obese patients present with a variety of skin changes. Herein, we discuss our own experience and review the complex skin changes in obesity. The role of metabolic syndrome and obesity are responsible for the epidemiological prevalence and are involved in the pathogenesis of chronic inflammatory skin diseases, such as psoriasis, atopic dermatitis, and skin malignancies. Here, we comment on the role of nutritional interventions in these patients as it has been proven that low-calorie diet and weight loss is related to improvement of inflammatory skin diseases. The readership of this paper will receive up-to-date overview on the connection between obesity and the skin that is of a practical importance to any clinician working in the field.

13 November 2012 in Journal of Biomedical Optics
Verified
Journal Article
Closed access
PDF file
RDRazvigor Borislavov Darlenski
Razvigor Borislavov Darlenski
JFJoachim W. Fluhr
Joachim W. Fluhr
Photodynamic therapy (PDT) is a noninvasive therapeutic method first introduced in the field of dermatology. It is mainly used for the treatment of precancerous and superficial malignant skin tumors. Today PDT finds new applications not only for nononcologic dermatoses but also in the field of other medical specialties such as otorhinolaryngology, ophthalmology, neurology, gastroenterology, and urology. We are witnessing a broadening of the spectrum of skin diseases that are treated by PDT. Since its introduction, PDT protocol has evolved significantly in terms of increasing method efficacy and patient safety. In this era of evidence-based medicine, it is expected that much effort will be put into creating a worldwide accepted consensus on PDT. A review on the current knowledge of PDT is given, and the historical basis of the method’s evolution since its introduction in the 1900s is presented. At the end, future challenges of PDT are focused on discussing gaps that exist for research in the field.

1 January 2018 in World Allergy Organization Journal
Verified
Journal Article
Open access
PKPavel Kolkhir
Pavel Kolkhir
DPDmitry Pogorelov
Dmitry Pogorelov
RDRazvigor Borislavov Darlenski
Razvigor Borislavov Darlenski
Marco CaminatiMarco Caminati
Marco Caminati
Luciana Kase TannoLuciana Kase Tanno
Luciana Kase Tanno
MMMarcus Maurer
Marcus Maurer
The approaches to the diagnosis and treatment of chronic spontaneous urticaria (CSU) differ in various parts of the world. We sought to determine the adherence to international and national urticaria guidelines as well as the motives to deviate from the guidelines among physicians worldwide. A web-based questionnaire was created and launched via e-mail by the World Allergy Organization (WAO) to representatives of all WAO Member Societies, the members of the American Academy of Allergy, Asthma & Immunology (AAAAI) and the members of the WAO Junior Members Group (JMG), regardless of the specialty, affiliation, or nationality in March 2017. We received 1140 completed surveys from participating physicians from 99 countries. Virtually all participants (96%) were aware of at least one urticaria guideline and reported that they follow a guideline. However, one in five physicians who follow a guideline (22%) reported to deviate from it. Reliance on own clinical experience is the most frequent reason for deviation from guidelines or not following them (44%). Young (< 40 years) and less experienced physicians more often follow a guideline and less often deviate than older and experienced ones. Physicians who follow a urticaria guideline showed higher rates of routinely ordering a complete blood count, the erythrocyte sedimentation rate, C-reactive protein, anti-thyroid antibodies, and thyroid-stimulating hormone and of performing the autologous serum skin test as compared to those who do not. Physicians who follow a urticaria guideline showed higher rates of using second generation antihistamines as their first-line treatment of CSU (p = 0.001) and more frequently observed higher efficacy of these drugs (or had more confidence that it would work, p < 0.019) as compared to those who do not follow the guidelines. Physicians' characteristics (e.g. age, clinical experience, and specialty) and country specifics and regional features (e.g. availability of drugs for CSU treatment) importantly influence adherence to urticaria guidelines and CSU patient care and should be addressed in more detail in future research.